IIC
CVS icon

Integrated Investment Consultants’s CVS Health CVS Stock Holding History

Integrated Investment Consultants’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,903
Closed -$219K – 289
2025
Q3 		$219K Sell
2,903
-597
-17% -$40.9K 0.04% 304
2025
Q2 		$241K Sell
3,500
-1,736
-33% -$114K 0.05% 281
2025
Q1 		$355K Sell
5,236
-134
-2% -$8.02K 0.07% 217
2024
Q4 		$241K Sell
5,370
-10,734
-67% -$602K 0.05% 264
2024
Q3 		$344K Buy
+16,104
New +$940K 0.07% 208
2018
Q2 		– Sell
-2,168
Closed -$135K – 290
2018
Q1 		$135K Buy
+2,168
New +$156K 0.05% 258
2017
Q3 		$180K Sell
2,215
-131
-6% -$10.4K 0.08% 172
2017
Q2 		$189K Sell
2,346
-324
-12% -$25.6K 0.09% 162
2017
Q1 		$210K Buy
2,670
+150
+6% +$12K 0.1% 140
2016
Q4 		$199K Sell
2,520
-128
-5% -$10.4K 0.1% 143
2016
Q3 		$233K Buy
2,648
+337
+15% +$31.8K 0.12% 110
2016
Q2 		$221K Buy
2,311
+280
+14% +$27.9K 0.13% 113
2016
Q1 		$206K Buy
+2,031
New +$197K 0.12% 114

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Integrated Investment Consultants's CVS Position: Q4 2025 in Review

Integrated Investment Consultants sold out of CVS Health (CVS) in Q4 2025, closing a stake of 2,903 shares — an estimated $219K sold.

Integrated Investment Consultants first reported a position in CVS in Q1 2016 and held it in 13 quarters. The position peaked at $355K in Q1 2025. 1,948 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

  • Integrated Investment Consultants reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
  • Integrated Investment Consultants sold 2,903 CVS Health shares in Q4 2025, an estimated $219K.
  • Integrated Investment Consultants first reported a position in CVS Health in Q1 2016 and held it in 13 quarters.
  • Integrated Investment Consultants's CVS Health position peaked at $355K in Q1 2025.
  • 1,948 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Integrated Investment Consultants's 13F filing for Q4 2025, filed 5 Feb 2026.